Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).
Related Content:
Thanking My Support System From My Cancer Journey
Ibtrozi May Address Unmet Needs In ROS1-Positive Non-Small Cell Lung Cancer
Actively Recruiting Trials for Lung, Biliary, AML and Small Cell Cancer
The Lessons of the Woods
